PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $265,755 | +458.7% | 164,046 | +486.3% | 0.00% | – |
Q1 2024 | $47,566 | -43.5% | 27,980 | +3.0% | 0.00% | – |
Q4 2023 | $84,249 | -64.8% | 27,177 | -30.4% | 0.00% | – |
Q3 2023 | $239,668 | -78.7% | 39,034 | -83.4% | 0.00% | – |
Q1 2023 | $1,123,082 | +78.0% | 235,447 | +224.7% | 0.00% | – |
Q4 2022 | $630,924 | +121.4% | 72,520 | +203.1% | 0.00% | – |
Q3 2022 | $285,000 | -19.9% | 23,927 | -4.2% | 0.00% | – |
Q2 2022 | $356,000 | -45.2% | 24,975 | -20.0% | 0.00% | – |
Q1 2022 | $650,000 | -54.7% | 31,200 | -25.7% | 0.00% | -100.0% |
Q2 2021 | $1,435,000 | +28.9% | 42,000 | +34.0% | 0.00% | 0.0% |
Q3 2020 | $1,113,000 | – | 31,349 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |